{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:32:37Z","timestamp":1790181157969,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Marcus Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157602","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T18:50:02Z","timestamp":1466103002000},"page":"e0157602","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":142,"title":["N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data"],"prefix":"10.1371","volume":"11","author":[{"given":"Daniel A.","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zabrecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kremens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsao-Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Wintering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiatao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Bazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Intenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Iacovitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Newberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"ref1","first-page":"39","article-title":"Parkinson\u2019s Disease","author":"M Korell","year":"2005"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"620674","DOI":"10.1155\/2015\/620674","article-title":"Psychological benefits of nonpharmacological methods aimed for improving balance in Parkinson's disease: A systematic review","volume":"2015","author":"R \u0160umec","year":"2015","journal-title":"Behav Neurol"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S1353-8020(13)70030-0","article-title":"Exercise: is it a neuroprotective and if so, how does it work?","volume":"20","author":"MJ Zigmond","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1345\/aph.1G551","article-title":"Antioxidants, supplements, and Parkinson's disease","volume":"40","author":"CA Weber","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1753-4887.2012.00484.x","article-title":"Nutraceuticals and their preventive or potential therapeutic value in Parkinson's disease","volume":"70","author":"J Chao","year":"2012","journal-title":"Nutr Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1098\/rstb.1985.0168","article-title":"Oxidative stress: damage to intact cells and organs","volume":"311","author":"H Sies","year":"1985","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","article-title":"Redox imbalance in Parkinson's disease","volume":"1780","author":"SJ Chinta","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine","volume":"34","author":"B Olsson","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"L Borgstr\u00f6m","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"MJ Holmay","year":"2013","journal-title":"Clin Neuropharmacol"},{"issue":"16","key":"ref11","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1046\/j.1432-1327.2000.01595.x","article-title":"Glutathione, oxidative stress and neurodegeneration","volume":"267","author":"JB Schulz","year":"2000","journal-title":"Eur J Biochem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ydbio.2013.01.012","article-title":"BMP and TGF-\u03b2 pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells","volume":"376","author":"J Cai","year":"2013","journal-title":"Dev Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mds.870120502","article-title":"The dopamine transporter: a crucial component regulating dopamine transmission","volume":"12","author":"M Jaber","year":"1997","journal-title":"Movement Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and methamphetamine in mice lacking the dopamine transporter","volume":"379","author":"B Giros","year":"1996","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410340331","article-title":"Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked decline in mild Parkinson's disease","volume":"34","author":"JJ Frost","year":"1993","journal-title":"Ann Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00501873","article-title":"Sodium dependent [3H] cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease","volume":"239","author":"H Shoemaker","year":"1985","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.90.24.11965","article-title":"Single-photon emission-computed tomography imaging demonstrates loss of striatal dopamine transporters in Parkinson disease","volume":"90","author":"RB Innis","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","first-page":"1500","article-title":"Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients","volume":"39","author":"JP Seibyl","year":"1998","journal-title":"J Nucl Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","article-title":"Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls","volume":"36","author":"SA Eshuis","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease","volume":"62","author":"J Booij","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00415-006-0322-9","article-title":"18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages","volume":"254","author":"J Wang","year":"2007","journal-title":"J Neurol"},{"issue":"7378","key":"ref22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"S Kriks","year":"2011","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1176\/appi.ajp.160.10.1836","article-title":"Greater availability of brain dopamine transporters in major depression shown by [(99m)Tc]TRODAT-1 SPECT imaging","volume":"160","author":"DJ Brunswick","year":"2003","journal-title":"Amer J Psych"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00259-014-2785-8","article-title":"Extrastriatal binding of [(123)I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls","volume":"41","author":"W Koch","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"ref25","first-page":"350","article-title":"Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane","volume":"32","author":"FJ Garc\u00eda-G\u00f3mez","year":"2013","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1098\/rstb.1985.0168","article-title":"Oxidative stress: damage to intact cells and organs","volume":"311","author":"H Sies","year":"1985","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410260409","article-title":"Striatal dopamine deficiency in Parkinson's disease: role of aging","volume":"26","author":"D Scherman","year":"1989","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"P Jenner","year":"1996","journal-title":"Neurology"},{"key":"ref29","first-page":"23","article-title":"Presymptomatic detection of Parkinson's disease","volume":"40","author":"P Jenner","year":"1993","journal-title":"J Neural Transm Suppl"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"P Jenner","year":"1996","journal-title":"Neurology"},{"issue":"Suppl 2","key":"ref31","first-page":"II3","article-title":"Pathoanatomy of Parkinson's disease","volume":"247","author":"H Braak","year":"2000","journal-title":"J Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"E Paxinou","year":"2001","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI200317638","article-title":"Oxidative stress and nitration in neurodegeneration: cause, effect, or association?","volume":"11","author":"H Ischiropoulos","year":"2003","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human \u03b1-synuclein","volume":"23","author":"VN Uversky","year":"2001","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","article-title":"Oxidative stress induces amyloid-like aggregate formation of NACP\/alpha-synuclein in vitro","volume":"10","author":"M Hashimoto","year":"1999","journal-title":"Neuroreport"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1471-4159.2006.04315.x","article-title":"Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease","volume":"100","author":"MP Thomas","year":"2007","journal-title":"J Neurochem"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/exnr.1996.0136","article-title":"Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease","volume":"141","author":"D Offen","year":"1996","journal-title":"Exp Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2013.09.049","article-title":"N-Acetyl cysteine blunts proteotoxicity in a heat shock protein-dependent manner","volume":"255","author":"Y Jiang","year":"2013","journal-title":"Neuroscience"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neulet.2013.12.023","article-title":"N-Acetyl cysteine prevents synergistic, severe toxicity from two hits of oxidative stress","volume":"560","author":"AS Unnithan","year":"2014","journal-title":"Neurosci Lett"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.14-07-04385.1994","article-title":"Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione","volume":"17","author":"RR Ratan","year":"1994","journal-title":"J Neurosci"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"e12333","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in \u03b1-synuclein over-expressing mice","volume":"5","author":"J Clark","year":"2010","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexmp.2008.10.004","article-title":"Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice","volume":"86","author":"E Aoki","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/hmg\/ddp501","article-title":"Phosphorylation of parkin by Parkinson disease linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling","volume":"19","author":"D Sha","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/10715760802158430","article-title":"Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson\u2019s disease","volume":"42","author":"MB Bagh","year":"2008","journal-title":"Free Radic Res"},{"key":"ref45","first-page":"424285","article-title":"N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells","author":"P Chandramani Shivalingappa","year":"2012","journal-title":"Parkinsons Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(97)00493-9","article-title":"N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria","volume":"762","author":"M Mart\u00ednez-Banaclocha","year":"1997","journal-title":"Brain Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01958877","article-title":"Effects of cysteine and N-acetyl cysteine on GSH content of brain of adult rats","volume":"39","author":"J Vina","year":"1983","journal-title":"Experientia"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0024-3205(98)00472-X","article-title":"Hypothesis: can N-acetylcysteine be beneficial in Parkinson\u2019s disease?","volume":"64","author":"M Mart\u00ednez-Banaclocha","year":"1999","journal-title":"Life Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(00)02005-9","article-title":"N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice. Implications for treatment of Parkinson\u2019s disease","volume":"859","author":"M Mart\u00ednez-Banaclocha","year":"2000","journal-title":"Brain Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(85)90229-0","article-title":"Partial protection from the dopaminergic neurotoxin Nmethyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse","volume":"60","author":"TL Perry","year":"1985","journal-title":"Neurosci Lett"},{"key":"ref51","first-page":"48","article-title":"Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigro-striatal toxicity in mice by N-acetyl cysteine","volume":"53","author":"A Sharma","year":"2007","journal-title":"Cell Mol Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/107157602100006445","article-title":"Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1\u201342","volume":"36","author":"S Medina","year":"2002","journal-title":"Free Radic Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22401","article-title":"Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease","volume":"24","author":"RA Hauser","year":"2009","journal-title":"Mov Disord"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pscychresns.2011.12.015","article-title":"Low brain serotonin transporter binding in major depressive disorder","volume":"202","author":"AB Newberg","year":"2012","journal-title":"Psychiatry Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neulet.2008.06.042","article-title":"Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study","volume":"441","author":"SM Lehto","year":"2008","journal-title":"Neurosci Lett"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.21894","article-title":"Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions","volume":"23","author":"CG Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00415-008-0849-z","article-title":"Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up","volume":"255","author":"S Hesse","year":"2008","journal-title":"J Neurol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","article-title":"Dopamine transporter brain imaging to assess the effects of pramipexole vs. levodopa on Parkinson disease progression","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study","volume":"54","author":"AL Whone","year":"2003","journal-title":"Ann Neurol"},{"issue":"3","key":"ref60","first-page":"311","article-title":"Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease","volume":"288","author":"JE Ahlskog","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jpsychires.2010.10.008","article-title":"The role and interpretation of pilot studies in clinical research","volume":"45","author":"AC Leon","year":"2011","journal-title":"J Psych Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T18:10:23Z","timestamp":1589047823000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157602"}},"subtitle":[],"editor":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157602","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}